Study on Optimization of Wet Milling Process for the Development of Albendazole Containing Nanosuspension with Improved Dissolution

被引:2
作者
Fulop, Viktor [1 ]
Jakab, Geza [1 ]
Toth, Bence [1 ]
Balogh, Emese [1 ]
Antal, Istvan [1 ]
机构
[1] Semmeiweis Univ, Fac Pharm, Dept Pharmaceut, Hogyes Endre St 7, H-1092 Budapest, Hungary
关键词
albendazole nanosuspension; wet media milling; dissolution improvement; Powder X-Ray Diffractometry (PXRD); Design Of Experiments (DOE); DRUG NANOSUSPENSIONS; ORAL BIOAVAILABILITY; FORMULATION; NANOCRYSTALS; DESIGN; SOLIDIFICATION; SIZE; NANOPARTICLES; POLYMORPHISM; ENHANCEMENT;
D O I
10.3311/PPch.15569
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
The main objective of this work was to show the potential of the optimization of top-down wet planetary bead milling process parameters (milling speed, process time and size of the milling medium) by Design Of Experiments (DOE) approach for the development of albendazole (ABZ) containing nanosuspension with improved dissolution. In addition, the influence of process parameters (capacity of milling container, applied volume of milling beads, size of the milling medium, milling speed, milling time) on ABZ polymorphic transition has also been investigated. The optimized, milled formula yielded - 145.39 times reduction in mean particle size (182.200 +/- 1.3130 nm) compared to unmilled dispersion, which demonstrated 13.50 times gain in mean dissolution rate value compared to the unmilled dispersion in medium at pH = 1.2. No lag time values were observed in the dissolution kinetics of the nanosuspension in comparison with the unmilled samples. Moreover, maximal mean solubility value was also improved by 1.45 times compared to the unmilled suspension, in medium at pH = 6.8, supporting the significance of the Ostwald-Freundlich equation. Diffraction pattern comparisons have indicated a polymorphic transition of albendazole to Form II, which was more pronounced in smaller container at high milling speed values and prolonged operations.
引用
收藏
页码:401 / 420
页数:20
相关论文
共 67 条
[11]   Enhanced Oral Bioavailability of Celecoxib Nanocrystalline Solid Dispersion based on Wet Media Milling Technique: Formulation, Optimization and In Vitro/In Vivo Evaluation [J].
Ding, Zhuang ;
Wang, Lili ;
Xing, Yangyang ;
Zhao, Yanna ;
Wang, Zhengping ;
Han, Jun .
PHARMACEUTICS, 2019, 11 (07)
[12]   Process induced disorder in crystalline materials: Differentiating defective crystals from the amorphous form of griseofulvin [J].
Feng, Tao ;
Pinal, Rodolfo ;
Carvajal, M. Teresa .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (08) :3207-3221
[13]   Ibuprofen nanocrystals developed by 22 factorial design experiment: A new approach for poorly water-soluble drugs [J].
Fernandes, A. R. ;
Ferreira, N. R. ;
Fangueiro, J. F. ;
Santos, A. C. ;
Veiga, F. J. ;
Cabral, C. ;
Silva, A. M. ;
Souto, E. B. .
SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (08) :1117-1124
[14]   Polymorphism of Mechanochemically Synthesized Cocrystals: A Case Study [J].
Fischer, Franziska ;
Heidrich, Adrian ;
Greiser, Sebastian ;
Benemann, Sigrid ;
Rademann, Klaus ;
Emmerling, Franziska .
CRYSTAL GROWTH & DESIGN, 2016, 16 (03) :1701-1707
[15]   Study on the dissolution improvement of albendazole using reconstitutable dry nanosuspension formulation [J].
Fulop, Viktor ;
Jakab, Geza ;
Bozo, Tamas ;
Toth, Bence ;
Endresik, Daniel ;
Balogh, Emese ;
Kellermayer, Miklos ;
Antal, Istvan .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 123 :70-78
[16]   Investigating a Novel Hot Melt Extrusion-Based Drying Technique to Solidify an Amorphous Nanosuspension Using Design of Experiment Methodology [J].
Gajera, Bhavin Y. ;
Shah, Dhaval A. ;
Dave, Rutesh H. .
AAPS PHARMSCITECH, 2018, 19 (08) :3778-3790
[17]   Albendazole generics - A comparative in vitro study [J].
Galia, E ;
Horton, J ;
Dressman, JB .
PHARMACEUTICAL RESEARCH, 1999, 16 (12) :1871-1875
[18]   Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology [J].
George, Maya ;
Ghosh, Indrajit .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (1-2) :142-152
[19]  
GlaxoSmithKline Pharmaceuticals Limited, ZENPI201802 GLAXOSMI
[20]   Quality-by-Design approach to the fluid-bed coating of ginkgo lactone nanosuspensions [J].
Han, Jiawei ;
Wang, Xin ;
Wang, Jingxian ;
Wang, Lingchong ;
Chen, Lihua ;
Li, Junsong ;
Li, Wen .
RSC ADVANCES, 2018, 8 (39) :22136-22145